Abstract
Many sex and gender differences in schizophrenic psychoses have been reported, but few have been soundly replicated. A stable finding is the later age of onset in women compared to men. Gender differences in symptomatology, comorbidity, and neurocognition seem to reflect findings in the general population. There is increasing evidence for estrogens being psychoprotective in women and for hypothalamic–pituitary–gonadal dysfunction in both sexes. More methodologically sound, longitudinal, multi-domain, interdisciplinary research investigating both sex (biological) and gender (psychosocial) factors is required to better understand the different pathogenesis and etiologies of schizophrenic psychoses in women and men, thereby leading to better tailored treatments and improved outcomes.
| Original language | English |
|---|---|
| Pages (from-to) | 627-648 |
| Number of pages | 22 |
| Journal | Archives of Women's Mental Health |
| Volume | 21 |
| Issue number | 6 |
| DOIs | |
| Publication status | Published - 1 Dec 2018 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Course
- Estrogens
- Gender
- Prolactin
- Psychosis
- Risk
- Schizophrenia
- Sex
- Symptoms
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver